Strategies to Allocate Scarce COVID-19 Monoclonal Antibody Treatments to Eligible Patients Examined in New Rapid Response to Government

Despite a scarce supply, a substantial amount of COVID-19 monoclonal antibody (mAb) treatment courses remain unused, says a new rapid expert consultation from the National Academies of Sciences, Engineering, and Medicine.
Source: News from the National Academies - Category: Science Source Type: news